Loading...

Dean Acheson

Title(s)Associate Clinical Professor, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #0851
La Jolla CA 92093
Phone9/5-43--8730
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Acheson received his B.A. in Psychology from Purdue University in 2003 and his Ph.D. in Clinical Psychology from the University at Albany, State University of New York in 2009. He completed predoctoral clinical internship and postdoctoral research training at the University of California-San Diego and VA San Diego Healthcare System. He joined the Psychiatry Department faculty in 2012. Dr. Acheson’s research attempts to understand the biobehavioral mechanisms involved in etiology and treatment of fear and anxiety-related disorders through the employment of cross-species translational paradigms with primarily psychophysiological outcomes (fear learning and extinction, prepulse inhibition). Dr. Acheson has a particular interest in facilitating learning-based mechanisms of psychotherapy via pharmacological intervention. Dr. Acheson currently serves as staff psychologist in the UCSD Obsessive Compulsive Treatment Program where he specializes in application of CBT/Exposure-based treatment strategies to “OC spectrum” disorders such as OCD, Body Dysmorphic Disorder, Compulsive Hoarding, and Habit Disorders.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sleep disturbance at pre-deployment is a significant predictor of post-deployment re-experiencing symptoms. Eur J Psychotraumatol. 2019; 10(1):1679964. Acheson DT, Kwan B, Maihofer AX, Risbrough VB, Nievergelt CM, Clark JW, Tu XM, Irwin MR, Baker DG. PMID: 31723377.
      View in: PubMed   Mentions:
    2. Characterizing the neural circuitry associated with configural threat learning. Brain Res. 2019 09 15; 1719:225-234. Stout DM, Glenn DE, Acheson DT, Simmons AN, Risbrough VB. PMID: 31173725.
      View in: PubMed   Mentions:    Fields:    
    3. A Review of the Relationship Between Emotional Learning and Memory, Sleep, and PTSD. Curr Psychiatry Rep. 2019 01 19; 21(1):2. Colvonen PJ, Straus LD, Acheson D, Gehrman P. PMID: 30661137.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. REM sleep and safety signal learning in posttraumatic stress disorder: A preliminary study in military veterans. Neurobiol Stress. 2018 Nov; 9:22-28. Straus LD, Norman SB, Risbrough VB, Acheson DT, Drummond SPA. PMID: 30116769.
      View in: PubMed   Mentions:
    5. Neural measures associated with configural threat acquisition. Neurobiol Learn Mem. 2018 04; 150:99-106. Stout DM, Glenn DE, Acheson DT, Spadoni AD, Risbrough VB, Simmons AN. PMID: 29544725.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Individual variation in working memory is associated with fear extinction performance. Behav Res Ther. 2018 03; 102:52-59. Stout DM, Acheson DT, Moore TM, Gur RC, Baker DG, Geyer MA, Risbrough VB. PMID: 29331727.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. The Future of Contextual Fear Learning for PTSD Research: A Methodological Review of Neuroimaging Studies. Curr Top Behav Neurosci. 2018; 38:207-228. Glenn DE, Risbrough VB, Simmons AN, Acheson DT, Stout DM. PMID: 29063483.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. COMT val158met polymorphism links to altered fear conditioning and extinction are modulated by PTSD and childhood trauma. Depress Anxiety. 2018 01; 35(1):32-42. Deslauriers J, Acheson DT, Maihofer AX, Nievergelt CM, Baker DG, Geyer MA, Risbrough VB. PMID: 28833952.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Fear learning alterations after traumatic brain injury and their role in development of posttraumatic stress symptoms. Depress Anxiety. 2017 08; 34(8):723-733. Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. PMID: 28489272.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Sleep Deprivation Disrupts Recall of Conditioned Fear Extinction. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Mar; 2(2):123-129. Straus LD, Acheson DT, Risbrough VB, Drummond SPA. PMID: 28758152.
      View in: PubMed   Mentions: 9     Fields:    
    11. HIGH AND LOW THRESHOLD FOR STARTLE REACTIVITY ASSOCIATED WITH PTSD SYMPTOMS BUT NOT PTSD RISK: EVIDENCE FROM A PROSPECTIVE STUDY OF ACTIVE DUTY MARINES. Depress Anxiety. 2016 Mar; 33(3):192-202. Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. PMID: 26878585.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Oxytocin enhancement of fear extinction: a new target for facilitating exposure-based treatments? Biol Psychiatry. 2015 Aug 01; 78(3):154-5. Acheson DT, Risbrough VB. PMID: 26143973.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Fear extinction memory performance in a sample of stable, euthymic patients with bipolar disorder. J Affect Disord. 2015 Oct 01; 185:230-8. Acheson DT, Eyler LT, Resovsky J, Tsan E, Risbrough VB. PMID: 26247493.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats. Dev Neurosci. 2015; 37(3):253-62. Powell SB, Khan A, Young JW, Scott CN, Buell MR, Caldwell S, Tsan E, de Jong LA, Acheson DT, Lucero J, Geyer MA, Behrens MM. PMID: 26022788.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    15. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response. Depress Anxiety. 2015 Jun; 32(6):400-7. Acheson DT, Feifel D, Kamenski M, Mckinney R, Risbrough VB. PMID: 25826649.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    16. Conditioned fear and extinction learning performance and its association with psychiatric symptoms in active duty Marines. Psychoneuroendocrinology. 2015 Jan; 51:495-505. Acheson DT, Geyer MA, Baker DG, Nievergelt CM, Yurgil K, Risbrough VB. PMID: 25444643.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    17. Fear conditioning, safety learning, and sleep in humans. J Neurosci. 2014 Aug 27; 34(35):11754-60. Marshall AJ, Acheson DT, Risbrough VB, Straus LD, Drummond SP. PMID: 25164670.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    18. Psychophysiology in the study of psychological trauma: where are we now and where do we need to be? Curr Top Behav Neurosci. 2014; 21:157-83. Acheson DT, Geyer MA, Risbrough VB. PMID: 25158622.
      View in: PubMed   Mentions: 2     Fields:    
    19. Sleep deprivation impairs performance in the 5-choice continuous performance test: similarities between humans and mice. Behav Brain Res. 2014 Mar 15; 261:40-8. van Enkhuizen J, Acheson D, Risbrough V, Drummond S, Geyer MA, Young JW. PMID: 24333377.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    20. Interoceptive sensitivity deficits in women recovered from bulimia nervosa. Eat Behav. 2013 Dec; 14(4):488-92. Klabunde M, Acheson DT, Boutelle KN, Matthews SC, Kaye WH. PMID: 24183142.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    21. Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development. Front Neurosci. 2013; 7:103. Acheson DT, Twamley EW, Young JW. PMID: 23785309.
      View in: PubMed   Mentions:
    22. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology (Berl). 2013 Sep; 229(1):199-208. Acheson D, Feifel D, de Wilde S, McKinney R, Lohr J, Risbrough V. PMID: 23644911.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    23. Effects of anxiolytic treatment on potentiated startle during aversive image anticipation. Hum Psychopharmacol. 2012 Jul; 27(4):419-27. Acheson DT, Stein MB, Paulus MP, Ravindran L, Simmons AN, Lohr JB, Risbrough VB. PMID: 22782542.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice. Neuropharmacology. 2012 Sep; 63(3):480-5. Acheson DT, Stein MB, Paulus MP, Geyer MA, Risbrough VB. PMID: 22575075.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    25. Interoceptive fear conditioning and panic disorder: the role of conditioned stimulus-unconditioned stimulus predictability. Behav Ther. 2012 Mar; 43(1):174-89. Acheson DT, Forsyth JP, Moses E. PMID: 22304889.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder. Neuropharmacology. 2012 Feb; 62(2):674-85. Acheson DT, Gresack JE, Risbrough VB. PMID: 21596050.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    27. Interoceptive fear conditioning as a learning model of panic disorder: an experimental evaluation using 20% CO(2)-enriched air in a non-clinical sample. Behav Res Ther. 2007 Oct; 45(10):2280-94. Acheson DT, Forsyth JP, Prenoveau JM, Bouton ME. PMID: 17548049.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    Dean's Networks
    Concepts (106)
    Derived automatically from this person's publications.
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _